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Abstract
Background: The aim of this paper is to present our own experience related to frequency of
symptomatic tachy- and bradyarrhythmias in patients after transcatheter closure of interatrial
defects (ASD) and patent foramen ovale (PFO) using Amplatzer plugs.
Methods: Transcatheter closure of interatrial communications with Amplatzer devices was
carried out on 739 patients in our center. Only patients with new symptomatic arrhythmias
(who required pharmacotherapy, cardioversion or pacemaker implantation) were included in
to the study. All patients who had had arrhythmias prior to ASD closure, such as supraven-
tricular tachycardias (SVT) or atrial flutter/fibrillation (AF), were excluded.
Results: New tachy- and bradyarrhythmias after implantation of Amplatzer devices were
observed in 11 patients (1.5%). There were 9 patients (mean age 36.7 years) with atrial
tachyarrhythmias (AF in 8 and SVT in 1 patients), which occurred between the first day and
3 months after implantation. Seven patients were treated initially by pharmacotherapy; in 2 of
them sinus rhythm returned just after cardioversion. In other 2 patients cardioversion was
performed as an initial therapy. In none of these patients, but one recurrence of tachycardia was
observed; however, 7 of them had pharmacotherapy prolonged up to 1 year. In 2 patients, aged
15 and 16, complete atrioventricular (AV) block was observed 4.3 and 1.5 years after Amplatzer
implantation, respectively. In the first patient intermittent second-degree AV block (Mobitz II) was
observed before ASD closure. In both patients, a DDDR pacemaker was implanted.
Conclusions: Transcatheter closure of ASD using Amplatzer devices is associated with a risk
of new atrial tachyarrhythmias (usually early after the procedure and in older patients). The
risk of conduction disturbances such as complete heart block, which can occur in late follow-
up, is low. Thence, close long-term follow-up of these patients is obligatory. (Cardiol J 2008; 15:
510–516)
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Introduction
Cases of arrhythmia after transcatheter closu-
re of interatrial communications are believed to be
a rare problem of minor clinical importance [1]. In
general they are mostly observed during the im-
plantation itself, and any deeper analyses of the
subject relate mostly to small series of patients.
The aim of this paper is to present our own
experience relating to the frequency of symptoma-
tic tachy- and bradyarrhythmias in patients after
transcatheter closure of interatrial defects (ASD)
and patent foramen ovale (PFO) using Amplatzer
plugs.
Methods
The data of 739 patients, in whom an attempt
of transcatheter closure of interatrial communica-
tions using Amplatzer plugs (AGA Med., Plymouth,
MN, USA) had been made, were analyzed. The pro-
cedures were performed between October 1997 and
June 2008. In 683 of them, ASDs were closed with
an Amplatzer Atrial Septal Occluder (ASO) or Cri-
briformis ASO (Crib ASO). The latter was used in
cases of multi-perforated defects. In 56 patients
with cryptogenous central nervous system strokes
the PFO was closed using the Amplatzer PFO Oc-
cluder (APFO). The intervention was successfully
accomplished in 712 (96.3%) patients. The reason
for the abandoned intervention in 27 patients with
ASD was improper ASO position (mostly in cases
of missing anterior-superior and floppy posterior-
inferior rim of the septum, but in no case because
of cardiac arrhythmia). The interventions were done
in a routine way using the methods described pre-
viously [2]. Data of ambulatory and eventual hospi-
talization files were analyzed for all patients. Fol-
low-up observation included ambulatory controls
within 1, 3, 6 and 12 months of intervention and then
yearly. The scope of interest covered any sympto-
matic arrhythmias: bradyarrhythmias (history of
weakness, syncope, unconsciousness) or atrial ta-
chyarrhythmias. The latter included events causing
substantial and lasting acute heart action accelera-
tion which required pharmaco- or electrotherapy
(cardioversion). These included acute supraventri-
cular tachycardias (SVT) as well as atrial flutter/fi-
brillation (AF) with fast ventricular action occurring
after implantation of the Amplatzer. Patients having
durable or intermittent atrial arrhythmia (SVT, AF)
prior to ASD closure and those with symptomless
arrhythmia or rhythm disturbances such as right His
bundle branch block, grade I atrio-ventricular (AV)
block, supraventricular extrasystole, etc. were exc-
luded from the study.
In each case of symptomatic tachy- and brady-
arrhythmia the patient’s data records prior to trans-
catheter closure of ASD/PFO were analyzed: occur-
rence of arrhythmia and/or conduction disturbances,
demographic data (age, body mass, height, gender),
grade of right ventricle enlargement, ASD diame-
ter or length of PFO channel in the transesophage-
al echocardiographic examination (TEE) and stret-
ched diameter. The course of procedure (including
the presence or absence of arrhythmia and/or con-
duction disturbances during implantation), size and
type of applied Amplatzer device, and device/height
ratio (D/H) were also analyzed. The latter parameter
was not calculated in cases of Crib ASO or APFO (for
technical reasons due to the narrow waist of the im-
plant). When arrhythmias or conduction disturbances
occurred, it was established how they were revealed,
their nature, how they were treated (efficiency of
pharmacotherapy and cardioversion in case of tachy-
arrhythmia) and whether re-occurrences took place.
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Results
Some new and symptomatic arrhythmias and
conduction disturbances not observed prior to the
intervention were found in 11 patients aged from
3.5 to 56 (mean 36.7) years. In 9 cases they were
acute and durable atrial tachycardias. In 2 girls (aged
15 and 16 years) symptomatic complete atrio-ven-
tricular block (CAVB) occurred. Clinical details of
all patients are shown in Table 1.
The analyzed material included 10 patients
with ASD and 1 with PFO. Among the patients with
ASD, 9 were treated with ASO (sized 9–40 mm) and
1 with 35 mm Crib ASO. In a single patient with
PFO a 35 mm APFO was applied. In all patients with
ASD the enlargement of the right ventricular cavity
(100–160% of body mass norm) was found. The D/H
ratio exceeded 0.2 in 1 case. There were no cases
without any arrhythmia or conduction disturbances
found during Amplatzer implantation.
Of the 9 patients with symptomatic atrial tachy-
arrhythmias, 8 of them were found to have AF and
1 was found to have SVT. Tachyarrhythmia occur-
red in 4 patients on the first day, in 3 patients in the
third week, in 1 patient during the second month and
in another 1 in the third month after the interven-
tion. In all of those patients stimulation of the vagus
nerve (Valsalva test etc.) was applied initially. As no
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effect was noticed, pharmacotherapy (adenosine,
propafenon or amiodarone, dosed intravenously) was
applied. In 2 patients the return of sinus rhythm was
not observed before cardioversion was applied.
In the next 2 patients cardioversion was applied as
a primary treatment. No recurrence of tachyarrhy-
thmia was observed in these patients (except for
one). In the case of an 8-year-old girl (Table 1 —
patient No. 6), within the first day after ASO implan-
tation SVT occurred and had to be managed by an
intravenous adenosine infusion. SVT repeated within
the fourth month and was treated by an intravenous
dosage of propranolol. In this case the beta-blocker
therapy was continued for 8 months, and within the
subsequent period of observation (covering
1 year after the last attack) no SVT recurrences were
observed. An extended (up to 1 year after interven-
tion) anti-arrhythmic treatment was also applied in
6 other patients (Table 1 — patient No. 1, 3, 4, 7, 8, 9).
Atrio-ventricular block occurred in 2 female
patients aged 15 and 16 years. It occurred 4.3 and
1.5 years after ASO implantation, respectively
(Table 1 — patient No. 2, 5). In both cases it reve-
aled by the presence of repeated weakness and syn-
cope reported in the clinical history. In the first pa-
tient, a 10-year-old girl, conduction disturbances
were already found prior to implantation — an inter-
mitting second-degree AV block of Mobitz type II. She
had 2 defects at a small distance (in TEE with dia-
meters of 8 and 3 mm). The size of the stretched
defect (a larger one) was 15 mm and such ASO was
used to obtain a complete closure of both ASDs (D/H
ratio = 0.11). During subsequent observation no
previously diagnosed AV block progression was
observed until clinical symptoms presented (mentio-
ned above) when intermittent AV block of grade III
was found. That was the reason for pacemaker im-
plantation (DDDR). In another girl, neither arrhy-
thmia nor conduction abnormalities were found
before or after ASO implantation (Fig. 1A, B). Her
ASD size in the TEE was 10 mm (Fig. 2A) and the
stretched diameter was 16 mm (Fig. 2B). For this
patient a 16 mm ASO was applied (Fig. 2C) and her
H/R ratio was 0.1. During the first 3 months after
implantation the girl complained of periodical he-
adaches and scotoma. In the control tests the sinus
rhythm was maintained; 1.5 years after ASO implan-
tation the patient was admitted to our department
with a symptomatic third-degree intermitting AV
block. The electrophysiological test was normal. In
24-hour ECG (Holter) recording CAVB with bre-
aks of up to 7 s (Fig. 3) was confirmed. After im-
plantation of a DDDR pacemaker the child has re-
mained asymptomatic for 1 year.Ta
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Figure 1. Normal ECG of 14-year-old girl after percuta-
neous procedure closure of atrial septal defect (A) limb
leads (B) precordial leads.
Figure 2. A. Atrial septal defect of 14-year-old girl
— transesophageal echocardiographic examination:
10 mm of diameter; B. Stretched diameter of interatrial
defects — 16 mm (balloon calibration); C. Amplatzer
Atrial Septal Occluder of 16 mm after implantation.
C
Discussion
Until now, the presented series of patients in
whom ASD was closed using ASO and in whom the
frequency of rhythm disturbances was analysed
consisted of from 23 to 423 patients [1–6]. Chessa
et al. [7] observed arrhythmia within the early post-
procedural period in 2.6% of patients (11/417). In our
material the occurrence of symptomatic tachyarr-
hythmias was lower at 1.3% (9/708), but cases of
benign temporary heart palpitation without clinical
manifestation were excluded. It must be emphasi-
zed that reported symptomatic tachyarrhythmias
occurred within an early postprocedural period: in
4 patients within the first day and in the next 5 after
hospital discharge (from 2 weeks to 4 months after
intervention). Their incidental nature is also impor-
tant (there was only one case of recurrence), altho-
ugh in 7 patients antiarrhythmic pharmacotherapy
up to 1 year after intervention was continued. They
occurred only in 2 cases in children (aged 3.5 and
8 years) and in 6 adults over 40 years old (in our
material 40% of the treated patients were adults).
According to our observations the appearance of
A
B
B
A
I
II
III
V1
V2
V3
V4
V5
V6
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tachyarrhythmias could be connected with the ap-
plication of large implants only in 2 patients. This
was related to a 56-year-old man in whom 40 mm
ASO was applied (D/H ratio 0.25). Atrial flutter/fi-
brillation with tachycardia appeared 3 weeks after
intervention. In a 3.5-year-old boy, a 19 mm ASO
was used (D/H ratio 0.19) and supraventricular ta-
chyarrhythmia appeared during the first day after
the procedure. No other factors (such as localiza-
tion of ASD, magnitude of right ventricular dilation,
etc.) predisposing to such complication were found.
Our material also included 2 patients with
symptomatic bradycardia caused by CAVB. In both,
rhythm disturbances occurred in a late period after
intervention — 4.3 and 1.5 years after implantation,
respectively. In the first case of a 10-year-old girl,
a second-degree AV block occurred even before the
intervention, so it can be supposed that the occur-
rence of a CAVB was caused by the progressive
nature of conduction abnormalities and there was
no dependence on whether or not the Amplatzer
was implanted. In the second case, involving
a 14-year-old girl, the closure was performed with
a 16 mm ASO and no rhythm disturbances were found
prior to implantation. It is generally found that AV
blocks, when observed during or after ASO implan-
tation, are temporary and reversible. Suda et al. [5]
found that their more frequent occurrence is asso-
ciated with implantation of ASO > 19 mm, a device/
/height ratio over 0.2 and a larger left-right shunt
through the ASD (Qp/Qs > 2.5). Such observations
were not confirmed in either of our 2 cases. We did
not determine the pulmonary/systemic flow ratio
because its credibility has recently been under qu-
estion [8], and in our opinion the right ventricle
overload is more substantial (results are presented
in Table 1). Potential mechanisms of conduction
abnormality after ASO implantation may be caused
Figure 3. The same patient — Holter ECG at the age of 16 years: intermittent third-degree atrioventricular block with
7 s pauses.
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by pressure and/or rubbing of the implant’s disk on
the artrio-ventricular node, a local oedema or pro-
gressive scar formation. The available literature
includes only single cases demonstrating the neces-
sity to implant a pacemaker due to a CAVB after
ASD closure with an Amplatzer. Hill et al. [6] re-
ported the case of a 6-year-old boy who needed
a pacemaker implantation after closure of a large
ASD using a 24 mm ASO. In that case, even prior
to intervention, the Holter test showed short nodal
rhythm episodes. The next patient in whom a pa-
cemaker had to be implanted was a 40-year-old
woman who experienced a permanent left His bun-
dle branch block and acute atrial fibrillation prior to
intervention. Transcatheter ASD closure was per-
formed with a 24 mm ASO according to stretched
diameter. After 2 months, acute atrial fibrillation oc-
curred with the necessity of intensive anti-arrhy-
thmic pharmacotherapy. Within the third month
after implantation the patient was admitted to the
hospital because of syncope and subsequent shock
caused by advanced grade II AV block. An endoca-
vitary electrode was implanted in an urgent mode
and it caused efficient stimulation. As the block was
progressing (up to CAVB), after a week a perma-
nent pacemaker DDD was implanted [9]. In the
literature some situations are reported when a CAVB
after ASO implantation has resolved after a long cor-
ticotherapy [10] or spontaneously soon after implan-
tation [5, 11]. Chessa et al. [7], after implantation
of an 18 mm ASO in a 7-year-old boy, observed
a complete AV block. The implant was withdrawn
and sinus rhythm restored. After a year, a 14 mm
ASO was implanted successfully without any con-
duction disturbances. The same author, in his com-
prehensive analysis of complications after transca-
theter ASD closure, reports a 29-year-old patient
who died suddenly 1.5 years after implantation of
an 18 mm ASO. This case might have been caused
by a late AV block, as happened to our patient.
Unfortunately, there is no evidence in the form of
ECG records, and no autopsy was performed.
It must be mentioned that there are reports
showing a relationship between surgical closure of
ASD and conduction abnormalities [12]. Recently,
a Mexican group presented a report covering
460 patients of various ages, after surgical ASD clo-
sure. They found arrhythmia and conduction distur-
bances in 6.3% of patients prior to intervention and
up to 14.31% afterwards. In 5 of them (1.2%),
a CAVB occurred, but only in 1 case with a previo-
us second-degree AV block [13]. In our material
presented here (739 patients after transcatheter
closure of interatrial communications using Amplat-
zer devices), serious conduction disturbances oc-
curred only in 2 patients (0.3%). Recently a muta-
tion in the NKX2-5 gene was found which causes
CAVB. Half of such autosomally-inheriting cases
refer to patients with ASD. Symptoms of this com-
plex (ASD – CAVB) are usually revealed in early
youth [14]. In the case of our patients, no such ge-
netic tests were carried out.
Conclusions
In the early period after transcatheter closure
of interatrial communications using Amplatzer de-
vices there is a risk of new atrial tachyarrhythmias,
of a somewhat temporary nature and in older per-
sons. The probability of late complete AV block after
such treatment is low but exists, so precise follow-
up of all patients is recommended.
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